Acadia Pharmaceuticals Stock Investor Sentiment
| ACAD Stock | USD 17.20 0.30 1.71% |
About 57% of ACADIA Pharmaceuticals' investor base is looking to short. The analysis of the overall investor sentiment regarding ACADIA Pharmaceuticals suggests that many traders are alarmed. The current market sentiment, together with ACADIA Pharmaceuticals' historical and current headlines, can help investors time the market. In addition, many technical investors use ACADIA Pharmaceuticals stock news signals to limit their universe of possible portfolio assets.
Comfort Level 43
Impartial
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use ACADIA Pharmaceuticals' input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward ACADIA Pharmaceuticals.
News SentimentBullish | Hype SentimentBearish | Insider SentimentDisposing |
ACADIA Historical Sentiment
Although ACADIA Pharmaceuticals' investment sentiment alone cannot always predict changes in its future share prices, when combined with other fundamental and technical analysis, a better chance to time the market can be gained. Certain informational and emotional events regarding ACADIA, such as negative comments on social media and news outlets, may cause fear in the market and push ACADIA Pharmaceuticals' investors to sell their holdings. The opposite can also be true when favorable news is released; it may translate into optimism and boost the price of ACADIA.
ACADIA |
ACADIA Pharmaceuticals Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards ACADIA Pharmaceuticals can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
ACADIA Pharmaceuticals Historical Investor Sentiment
Investor biases related to ACADIA Pharmaceuticals' public news can be used to forecast risks associated with an investment in ACADIA. The trend in average sentiment can be used to explain how an investor holding ACADIA can time the market purely based on public headlines and social activities around ACADIA Pharmaceuticals. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
ACADIA Pharmaceuticals' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for ACADIA Pharmaceuticals and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average ACADIA Pharmaceuticals news discussions. The higher the estimate score, the more favorable the investor's outlook on ACADIA Pharmaceuticals.
Far too much social signal, news, headlines, and media speculation about ACADIA Pharmaceuticals that are available to investors today. That information is available publicly through ACADIA media outlets and privately through word of mouth or via ACADIA internal channels. However, regardless of the origin, that massive amount of ACADIA data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of ACADIA Pharmaceuticals news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of ACADIA Pharmaceuticals relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to ACADIA Pharmaceuticals' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive ACADIA Pharmaceuticals alpha.
ACADIA Pharmaceuticals Performance against Dow Jones
Price Growth (%) |
| Timeline |
1 | Disposition of 9913 shares by Brendan Teehan of ACADIA Pharmaceuticals subject to Rule 16b-3 | 12/20/2024 |
2 | ACADIA Pharmaceuticals Submits MAA for Trofinetide to EMA | 01/14/2025 |
3 | Disposition of 31747 shares by Davis Stephen of ACADIA Pharmaceuticals at 15.28 subject to Rule 16b-3 | 01/22/2025 |
4 | ACADIA HEALTHCARE INVESTIGATION INITIATED by Former Louisiana Attorney General Kahn Swick ... | 02/11/2025 |
5 | Disposition of 1353 shares by Mark Schneyer of ACADIA Pharmaceuticals subject to Rule 16b-3 | 02/21/2025 |
6 | Disposition of 773 shares by Mark Schneyer of ACADIA Pharmaceuticals at 19.96 subject to Rule 16b-3 | 02/24/2025 |
7 | ACADIA Pharmaceuticals Q4 Earnings EPS Soars to 0. ... | 02/26/2025 |
8 | ACADIA Pharmaceuticals Inc. Receives Consensus Recommendation of Moderate Buy from Analysts | 02/28/2025 |
9 | Acadia Pharmaceuticals and Saniona Announce Initial Positive Results from ACP-711 Phase 1 Study | 03/03/2025 |
10 | Clinical Data from Open-Label DAFFODIL Study Evaluating Long-term Safety of DAYBUE in Patients with Rett Syndrome Published in Med | 03/05/2025 |
11 | Insider Sell Elizabeth Garofalo Sells 4,919 Shares of ACADIA Pharmaceuticals Inc | 03/07/2025 |
12 | Acadia Sets Stage for Strategic Updates at 3 Major CNS Conferences - Key Dates for Investors - StockTitan | 03/13/2025 |
13 | Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635 | 03/14/2025 |
Complementary Tools for ACADIA Stock analysis
When running ACADIA Pharmaceuticals' price analysis, check to measure ACADIA Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ACADIA Pharmaceuticals is operating at the current time. Most of ACADIA Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of ACADIA Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ACADIA Pharmaceuticals' price. Additionally, you may evaluate how the addition of ACADIA Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |